640 related articles for article (PubMed ID: 6967702)
1. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
2. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
Marceau F; Hugli TE
J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
[TBL] [Abstract][Full Text] [Related]
3. Mast cells are not required for anaphylatoxin-induced ileal smooth muscle contraction.
Stimler-Gerard NP; Galli SJ
J Immunol; 1987 Mar; 138(6):1908-13. PubMed ID: 2434565
[TBL] [Abstract][Full Text] [Related]
4. Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin.
Stimler NP; Bach MK; Bloor CM; Hugli TE
J Immunol; 1982 May; 128(5):2247-52. PubMed ID: 6174625
[TBL] [Abstract][Full Text] [Related]
5. Microvascular effects of anaphylatoxins C3a and C5a.
Björk J; Hugli TE; Smedegård G
J Immunol; 1985 Feb; 134(2):1115-9. PubMed ID: 3871207
[TBL] [Abstract][Full Text] [Related]
6. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
7. Human C5a des Arg increases vascular permeability.
José PJ; Forrest MJ; Williams TJ
J Immunol; 1981 Dec; 127(6):2376-80. PubMed ID: 6170701
[TBL] [Abstract][Full Text] [Related]
8. Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses.
Stimler-Gerard NP
Complement; 1986; 3(3):137-51. PubMed ID: 3026723
[TBL] [Abstract][Full Text] [Related]
9. Induction of platelet aggregation by the complement-derived peptides C3a and C5a.
Grossklaus C; Damerau B; Lemgo E; Vogt W
Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):71-6. PubMed ID: 1004644
[TBL] [Abstract][Full Text] [Related]
10. C5a-induced aortic contraction: effect of an antihistamine and inhibitors of arachidonate metabolism.
Regal JF
J Pharmacol Exp Ther; 1982 Jan; 220(1):102-7. PubMed ID: 6118427
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue.
Huey R; Bloor CM; Kawahara MS; Hugli TE
Am J Pathol; 1983 Jul; 112(1):48-60. PubMed ID: 6859228
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of a specific C3a receptor on guinea pig platelets.
Fukuoka Y; Hugli TE
J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237
[TBL] [Abstract][Full Text] [Related]
13. Effects of human anaphylatoxins on guinea pig atria.
Huey R; Bloor CM; Hugli TE
Immunopharmacology; 1984 Dec; 8(3-4):147-54. PubMed ID: 6335143
[TBL] [Abstract][Full Text] [Related]
14. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
[TBL] [Abstract][Full Text] [Related]
15. Anaphylactic actions of platelet-activating factor.
Stimler NP; Bloor CM; Hugli TE; Wykle RL; McCall CE; O'Flaherty JT
Am J Pathol; 1981 Oct; 105(1):64-9. PubMed ID: 6975043
[TBL] [Abstract][Full Text] [Related]
16. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
Gerard C; Hugli TE
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
[TBL] [Abstract][Full Text] [Related]
17. A differential effect of C5a and C5a des Arg in the induction of pulmonary inflammation.
Larsen GL; McCarthy K; Webster RO; Henson J; Henson PM
Am J Pathol; 1980 Jul; 100(1):179-92. PubMed ID: 7395964
[TBL] [Abstract][Full Text] [Related]
18. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
Haeger M; Bengtson A; Karlsson K; Heideman M
Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
[TBL] [Abstract][Full Text] [Related]
19. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
Sorgenfrei J; Damerau B; Vogt W
Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
[TBL] [Abstract][Full Text] [Related]
20. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects.
del Balzo U; Polley MJ; Levi R
J Pharmacol Exp Ther; 1988 Sep; 246(3):911-6. PubMed ID: 2458450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]